Comparative Analysis of Single-Nucleus and Single-Cell RNA Sequencing in Human Bone Marrow Mononuclear Cells: Methodological Insights and Trade-offs

Mohammad Reza Eftekhariyan Ghamsari, Carolyn A. de Graaf, Rachel Thijssen, Yupei You, Nigel H. Lovell, Hamid Alinejad‐Rokny, Matthew E. RitchiebioRxiv 2025 · DOI

Abstract: Bone marrow mononuclear cells (BMMCs) are a heterogeneous pool of hematopoietic progenitors and mature immune cells that collectively sustain hematopoiesis and coordinate immune responses. Advances in single-cell RNA sequencing (scRNA-seq) and single-nucleus RNA sequencing (snRNA-seq) have significantly enhanced our understanding of the cellular biology and molecular dynamics within this complex microenvironment. The choice between these two approaches, however, is often shaped or constrained by the study design, such as research objectives, sample type, and preservation conditions. In this study, we conducted a comparative analysis of matched snRNA-seq and scRNA-seq datasets from 11 pairs of healthy donor bone marrow mononuclear cell samples, generated using the 10x Genomics platform. We evaluated method-specific biases using multiple quality metrics and compared cell type proportions and transcriptomic signatures captured by each approach. Integrative analysis of these datasets is feasible but not advisable due to systematic gene length biases observed between these approaches. Our results showed that despite inherent differences in library complexity, both protocols reliably captured all major cell types. This comparative analysis highlights intrinsic differences between snRNA-seq and scRNA-seq data, providing valuable insights into their respective advantages, limitations, and trade-offs.

Introduction

Bone marrow mononuclear cells (BMMCs) represent a complex "soup" of stem cells, progenitors, and mature immune cells. Characterizing this environment is crucial for understanding hematopoiesis and various blood-related disorders. To achieve this, researchers increasingly rely on single-cell technologies. However, a fundamental choice must be made: sequence the whole cell (scRNA-seq) or just the nucleus (snRNA-seq)?

While scRNA-seq is considered the gold standard, it requires fresh tissue and involves harsh enzymatic dissociation that can induce cellular stress or lead to the loss of fragile cell populations. Conversely, snRNA-seq is compatible with frozen samples and bypasses dissociation-induced biases, but it only captures the transcriptomic snapshot present within the nucleus. This study provides a comprehensive "head-to-head" comparison across multiple donors and laboratories to determine the comparability and specific biases of these two methodologies in the context of human bone marrow.

Methodological Framework

The researchers employed a "biology-aware" analytical framework to compare the technologies using the standard 10x Genomics Chromium platform. The study utilized a matched design where samples from the same donor were split, with one half processed as whole cells and the other as isolated nuclei.

Overview of the experimental and computational workflow for comparing scRNA-seq and snRNA-seq.

Key to their approach was an adaptive Quality Control (QC) strategy. Rather than applying rigid global filters, the team used a data-driven method to identify low-quality cells at the cluster level. This allowed for the preservation of rare cell types that might naturally exhibit lower RNA counts, which traditional filtering might inadvertently discard. To compare transcriptomic signatures, counts were aggregated by cell type (pseudo-bulk) for differential expression analysis (DEA). Finally, the Harmony algorithm was used to evaluate the feasibility of data integration.

Comparative Quality Metrics and Library Complexity

The analysis revealed distinct technical profiles for each method. scRNA-seq samples generally exhibited higher library complexity and a greater dynamic range of gene expression, making them slightly more sensitive to subtle transcriptional differences. However, scRNA-seq was also significantly more susceptible to ambient RNA contamination and showed higher proportions of mitochondrial (MT) gene transcripts, often an indicator of cellular stress during processing.

Comparison of quality control metrics between scRNA-seq and snRNA-seq across multiple donors and laboratories.

In contrast, snRNA-seq captured a much higher proportion of intronic reads (unspliced pre-mRNA). This high intronic content effectively "compensated" for the lower total mRNA volume in the nucleus, allowing snRNA-seq to remain competitive with scRNA-seq in terms of total gene detection. Furthermore, scRNA-seq demonstrated higher Jaccard similarity for Highly Variable Genes (HVGs) across different laboratories, suggesting it may be more robust to site-specific effects than snRNA-seq.

Systematic Gene-Length Bias and Intronic Compensation

A major finding of the study is the presence of a systematic gene-length bias. snRNA-seq consistently favored the capture of longer genes, whereas scRNA-seq was enriched for shorter transcripts. This bias is likely a physical consequence of how transcripts are captured and processed within the nucleus versus the cytoplasm. This discovery is critical because it suggests that the differences between the two methods are not merely stochastic but are rooted in the biological distribution of RNA.

Cell Type Sensitivity and Integration Challenges

Despite technical differences, both protocols successfully identified 15 major cell types within the bone marrow. However, cell type sensitivity varied. Specifically, erythroblasts and reticulocytes—cells that are in the process of losing or have already lost their nuclei—were significantly underrepresented in snRNA-seq datasets.

While computational tools like Harmony can successfully merge scRNA-seq and snRNA-seq data into a single visualization (such as a UMAP), the authors issue a strong warning: the underlying gene-length biases can lead to misleading interpretations. Directly comparing gene expression levels between the two methods without accounting for these systematic differences can result in false biological conclusions.

Conclusion

This comparative analysis highlights that while scRNA-seq and snRNA-seq are broadly consistent in identifying cell populations, they are not interchangeable. scRNA-seq remains preferable for studies involving non-nucleated cells or requiring high sensitivity for short transcripts. snRNA-seq is an excellent alternative for frozen clinical cohorts and avoids dissociation-related artifacts. Researchers should select their method based on specific biological questions and sample availability, and future work should focus on developing normalization algorithms that explicitly account for gene-length biases to enable safer cross-method data integration.

Summary updated

Abstract

Bone marrow mononuclear cells (BMMCs) are a heterogeneous pool of hematopoietic progenitors and mature immune cells that collectively sustain hematopoiesis and coordinate immune responses. The bone marrow serves not only as the primary site for blood cell production but also as a niche for various disorders, including blood cancers. Advances in single-cell RNA sequencing (scRNA-seq) and single-nucleus RNA sequencing (snRNA-seq) have significantly enhanced our understanding of the cellular biology and molecular dynamics within this complex microenvironment. The choice between these two approaches, however, is often shaped or constrained by the study design, such as research objectives, sample type, and preservation conditions. Consequently, methodological differences in library preparation and transcript capture efficiency can introduce systematic biases that complicate downstream analyses and interpretation, underscoring the need to identify and account for method-specific features. In this study, we conducted a comparative analysis of matched snRNA-seq and scRNA-seq datasets from 11 pairs of healthy donor bone marrow mononuclear cell samples, generated using the popular 10x Genomics platform. We evaluated method-specific biases using multiple quality metrics and compared cell type proportions and transcriptomic signatures captured by each approach. Integrative analysis of these datasets is feasible but not advisable due to systematic gene length biases that were observed between these approaches. Our results showed that despite inherent differences in library complexity, both protocols reliably captured all major cell types. This comparative analysis highlights intrinsic differences between snRNA-seq and scRNA-seq data, providing valuable insights into their respective advantages, limitations, and trade-offs. These findings can assist researchers in selecting the optimal method tailored to specific biological questions and sample characteristics, and also enable more method-aware data analysis and interpretation.
BibTeX
@misc{ghamsari2025comparative,
  author = {Mohammad Reza Eftekhariyan Ghamsari and Carolyn A. de Graaf and Rachel Thijssen and Yupei You and Nigel H. Lovell and Hamid Alinejad‐Rokny and Matthew E. Ritchie},
  title = {{Comparative Analysis of Single-Nucleus and Single-Cell RNA Sequencing in Human Bone Marrow Mononuclear Cells: Methodological Insights and Trade-offs}},
  year = {2025},
  doi = {10.1101/2025.09.08.675012},
  howpublished = {bioRxiv},
}
Figure